Kalaris Therapeutics (KLRS) Other Gross PP&E Adjustments (2019 - 2020)
Kalaris Therapeutics (KLRS) has 2 years of Other Gross PP&E Adjustments data on record, last reported at -$10.8 million in Q3 2020.
- For Q3 2020, Other Gross PP&E Adjustments fell 72.05% year-over-year to -$10.8 million; the TTM value through Sep 2020 reached -$10.8 million, down 72.05%, while the annual FY2019 figure was -$11.8 million, N/A changed from the prior year.
- Other Gross PP&E Adjustments reached -$10.8 million in Q3 2020 per KLRS's latest filing, up from -$11.0 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$6.3 million in Q3 2019 and bottomed at -$11.8 million in Q4 2019.